Skip to main content
SpringerLink
Log in

FDG-PET for predicting the prognosis of malignant lymphoma

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

To evaluate the usefulness of FDG-PET as a predictor of prognosis, 34 patients with untreated malignant lymphoma in the head and neck region were studied. After FDG-PET and treatment, they were observed from 15 to 50 months. Tumors which were aggressive and resistant to treatment tended to show high uptake of FDG. The survival rate of patients with high uptake of FDG, DAR > 8, was lower than the rate of the other patients. It is considered to be useful to add FDG uptake of the tumor to other prognostic factors for predicting the prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, et al. The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis.J Nucl Med 32: 686–691, 1991.

    CAS  PubMed  Google Scholar 

  2. Okada J, Yoshikawa K, Itami M, Imaseki K, Uno K, Itami J, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity.J Nucl Med 33: 325–329, 1992.

    CAS  PubMed  Google Scholar 

  3. Schrape S, Jones DB, Wright DH. A comparison of three methods for the determination of the growth fraction in non-Hodgkin’s lymphoma.Br J Cancer 55: 283–286, 1987.

    CAS  PubMed  Google Scholar 

  4. Hall PA, Richards MA, Gregory WM, d’Ardenne AJ, Lister TA, Stansfeld A. The prognostic value of Ki-67 immunostaining in non-Hodgkin’s lymphoma.J Pathol 1554: 223–235, 1988.

    Article  Google Scholar 

  5. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET.J Nucl Med 29: 181–186, 1988.

    CAS  PubMed  Google Scholar 

  6. Griffeth LK, Dehdashti F, Mcguire AH, et al. PET evaluation of soft-tissue masses with fluorine-2-deoxy-Dglucose.Radiology 182: 185–194, 1992.

    CAS  PubMed  Google Scholar 

  7. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxy glucose PET: characterization of tumor and assessment of effect of treatment.J Nucl Med 33: 333–339, 1992.

    CAS  PubMed  Google Scholar 

  8. Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.J Nucl Med 34: 1420–1427, 1993.

    CAS  PubMed  Google Scholar 

  9. Leskinen-Kallio S, Ruotsalainen U, Nagren K, Teraes M, Joensusu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin’s lymphoma: a PET study.J Nucl Med 32: 1211–1218, 1991.

    CAS  PubMed  Google Scholar 

  10. Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography.J Neurosurg 62: 816–822, 1985.

    Article  CAS  PubMed  Google Scholar 

  11. National Cancer Institute. Study of classifications on non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage.Cancer 49: 2112–2135, 1982.

    Article  Google Scholar 

  12. Fukuda M, Matuzawa T, Ito M. Clinical evaluation of cancer diagnosis with 18F-2-fluoro-D-glucose. Its usefulness in liver and pancreas cancers.CYRIC Annual Report, Tohoku University, pp. 244–250, 1983.

  13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 53: 457–481, 1958.

    Article  Google Scholar 

  14. Cox DR. Regression models and life tables.J Royal Stat Soc Series B 34: 187–229, 1972.

    Google Scholar 

  15. Patlak CS, Blasberg RG, Frenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.J Cereb Blood Flow Metab 3: 1–7, 1983.

    CAS  PubMed  Google Scholar 

  16. Gjedde A, Wienhard K, Heiss WD, et al. Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients with special reference to the regional estimation of the lumped constant.J Cereb Blood Flow Metab 5: 163–178, 1985.

    CAS  PubMed  Google Scholar 

  17. Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss WD. Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures.J Cereb Blood Flow Metab 5: 115–125, 1985.

    CAS  PubMed  Google Scholar 

  18. Fischman AJ, Alpert NM. FDG-PET in oncology: There’s more to it than looking at pictures.J Nucl Med 34: 6–11, 1993.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Narita Red Cross Hospital, 90-1, Iida-cho, Narita, 286, Chiba, Japan

    Junichi Okada & Hiroshi Oonishi

  2. Department of Radiology, Chiba University Hospital, Japan

    Kyosan Yoshikawa, Jun Itami, Kimiichi Uno, Keiko Imaseki & Noboru Arimizu

Authors
  1. Junichi Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Oonishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kyosan Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Itami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kimiichi Uno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keiko Imaseki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Noboru Arimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okada, J., Oonishi, H., Yoshikawa, K. et al. FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 8, 187–191 (1994). https://doi.org/10.1007/BF03164996

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164996

Key words

Search

Navigation